Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
China · Delayed Price · Currency is CNY 19.70
-0.11 (-0.56%)
Feb 13, 2026, 3:00 PM CST
SHA:688670 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -126.51 | -93.5 | -70.99 | 41.54 | 82.46 | 154.98 |
Depreciation & Amortization | 28.82 | 28.82 | 29.87 | 29.76 | 28.08 | 25.81 |
Other Amortization | 1.6 | 1.6 | 1.38 | 1.38 | 1.13 | - |
Loss (Gain) From Sale of Assets | 0.1 | 0.1 | - | -0.23 | 0.05 | -0 |
Asset Writedown & Restructuring Costs | 4.68 | 4.68 | 1.11 | 38.35 | 57.94 | 1.13 |
Loss (Gain) From Sale of Investments | -12.18 | -12.18 | -13.1 | -14.13 | -7.26 | -0.4 |
Provision & Write-off of Bad Debts | 2.68 | 2.68 | -11.25 | 1.15 | - | - |
Other Operating Activities | 50.71 | 21.5 | 56.69 | 1.28 | 9.85 | 9.64 |
Change in Accounts Receivable | -13.82 | -13.82 | 241.61 | -7.19 | 13.37 | -307.64 |
Change in Inventory | -32.85 | -32.85 | -44.83 | -39.03 | -48.91 | -14.83 |
Change in Accounts Payable | -15.95 | -15.95 | -93.99 | -18.82 | -20.13 | 160.25 |
Change in Other Net Operating Assets | - | - | - | 0.76 | 0.73 | 14.99 |
Operating Cash Flow | -135.18 | -131.39 | 80.9 | 38.6 | 103.93 | 109.46 |
Operating Cash Flow Growth | - | - | 109.62% | -62.86% | -5.05% | - |
Capital Expenditures | -51.77 | -38.48 | -54 | -168.18 | -386.39 | -40.81 |
Sale of Property, Plant & Equipment | 0.03 | 0.27 | - | - | 0.05 | 0.02 |
Investment in Securities | 188.98 | 188.98 | -145 | 280.87 | -615 | -30.87 |
Other Investing Activities | 4.42 | -4.18 | 11.3 | - | 4.95 | 0.4 |
Investing Cash Flow | 141.66 | 146.59 | -187.71 | 112.7 | -996.39 | -71.26 |
Short-Term Debt Issued | - | 74.6 | 66 | 52 | 229.61 | - |
Total Debt Issued | 68 | 74.6 | 66 | 52 | 229.61 | - |
Short-Term Debt Repaid | - | -91 | -44 | -20 | -515.96 | -323.35 |
Total Debt Repaid | -69.6 | -91 | -44 | -20 | -515.96 | -323.35 |
Net Debt Issued (Repaid) | -1.6 | -16.4 | 22 | 32 | -286.35 | -323.35 |
Issuance of Common Stock | - | - | - | - | 1,150 | 374.05 |
Common Dividends Paid | -1.31 | -1.63 | -17.6 | -45.25 | - | -8.44 |
Other Financing Activities | - | - | -1.88 | - | -22.98 | - |
Financing Cash Flow | -2.91 | -18.03 | 2.52 | -13.25 | 841.14 | 42.27 |
Foreign Exchange Rate Adjustments | - | - | - | 0 | - | - |
Net Cash Flow | 3.56 | -2.82 | -104.29 | 138.04 | -51.33 | 80.46 |
Free Cash Flow | -186.95 | -169.86 | 26.9 | -129.58 | -282.46 | 68.65 |
Free Cash Flow Margin | -160.39% | -210.22% | 19.99% | -40.69% | -72.01% | 11.65% |
Free Cash Flow Per Share | -1.53 | -1.38 | 0.22 | -1.06 | -2.69 | 0.74 |
Cash Interest Paid | - | - | 1.88 | - | 9.85 | - |
Cash Income Tax Paid | 4.93 | 5.01 | 7.27 | 20.62 | 43.48 | 19.52 |
Levered Free Cash Flow | -80.69 | -123.83 | 93.07 | -80.61 | -297.59 | -41.66 |
Unlevered Free Cash Flow | -79.87 | -122.83 | 94.26 | -79.81 | -291.44 | -35.64 |
Change in Working Capital | -85.09 | -85.09 | 87.2 | -60.5 | -69.59 | -97.28 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.